Literature DB >> 28832953

Colchicine: an ancient drug with novel applications.

B Dasgeb1,2, D Kornreich1, K McGuinn1, L Okon1, I Brownell3, D L Sackett4.   

Abstract

Colchicine is a treatment for gout that has been used for more than a millennium. It is the treatment of choice for familial Mediterranean fever and its associated complication, amyloidosis. The 2009 U.S. Food and Drug Administration approval of colchicine as a new drug had research consequences. Recent investigations with large cohorts of patients with gout who have been taking colchicine for years have demonstrated novel applications within oncology, immunology, cardiology and dermatology. Some emerging dermatological uses include the treatment of epidermolysis bullosa acquisita, leucocytoclastic vasculitis, aphthous stomatitis and others. In this work we relate the history and the new horizon of this ancient medicine.
© 2017 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28832953      PMCID: PMC5812812          DOI: 10.1111/bjd.15896

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  57 in total

Review 1.  Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale.

Authors:  Edina Komlodi-Pasztor; Dan L Sackett; Antonio Tito Fojo
Journal:  Clin Cancer Res       Date:  2012-01-01       Impact factor: 12.531

Review 2.  Colchicine in clinical medicine. A guide for internists.

Authors:  Giuseppe Cocco; David C C Chu; Stefano Pandolfi
Journal:  Eur J Intern Med       Date:  2010-11-05       Impact factor: 4.487

3.  Colchicine and indomethacin for the treatment of relapsing polychondritis.

Authors:  Kenneth A Mark; Andrew G Franks
Journal:  J Am Acad Dermatol       Date:  2002-02       Impact factor: 11.527

4.  Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action.

Authors:  C Marques-da-Silva; M M Chaves; N G Castro; R Coutinho-Silva; M Z P Guimaraes
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Comparison of colchicine versus prednisolone in recurrent aphthous stomatitis: A double-blind randomized clinical trial.

Authors:  Atessa Pakfetrat; Arash Mansourian; Fatemeh Momen-Heravi; Zahra Delavarian; Jalil Momen-Beitollahi; Omid Khalilzadeh; Samira Basir-Shabestari
Journal:  Clin Invest Med       Date:  2010-06-01       Impact factor: 0.825

6.  Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.

Authors:  Fereydoun Davatchi; Bahar Sadeghi Abdollahi; Arash Tehrani Banihashemi; Farhad Shahram; Abdolhadi Nadji; Hormoz Shams; Cheyda Chams-Davatchi
Journal:  Mod Rheumatol       Date:  2009-07-14       Impact factor: 3.023

7.  Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis.

Authors:  Gregory C Borstad; Leslie R Bryant; Michael P Abel; Daren A Scroggie; Mark D Harris; Jeff A Alloway
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

8.  Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses.

Authors:  A Akar; H Bülent Taştan; H Erbil; E Arca; Z Kurumlu; A R Gür
Journal:  J Dermatolog Treat       Date:  2001-12       Impact factor: 3.359

9.  Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever.

Authors:  D Zemer; M Pras; E Sohar; M Modan; S Cabili; J Gafni
Journal:  N Engl J Med       Date:  1986-04-17       Impact factor: 91.245

10.  Effect of colchicine in the subcorneal pustular dermatosis type of IgA pemphigus.

Authors:  E Hodak; M Lapidoth; M David
Journal:  J Am Acad Dermatol       Date:  1999-01       Impact factor: 11.527

View more
  34 in total

1.  N-Doped Carbon Dots as a Fluorescent Nanosensor for Determination of Colchicine Based on Inner Filter Effect.

Authors:  Samah F El-Malla; Eman A Elshenawy; Sherin F Hammad; Fotouh R Mansour
Journal:  J Fluoresc       Date:  2021-02-10       Impact factor: 2.217

2.  Colchicine in the treatment of refractory aphthous ulcerations: Review of the literature and two case reports.

Authors:  Mihaela Paula Toader; Irina Mihaela Esanu; Tatiana Taranu; Madalina Mocanu; Stefan Toader
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

3.  Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation.

Authors:  Jui-Hsia Weng; Peter David Koch; Harding Luan; Ho-Chou Tu; Kenichi Shimada; Iris Ngan; Richard Ventura; Ruomu Jiang; Timothy J Mitchison
Journal:  Nat Metab       Date:  2021-04-12

Review 4.  Recurrent Aphthous Stomatitis: Treatment and Management.

Authors:  Marco Manfredini; Stefania Guida; Matteo Giovani; Nicola Lippolis; Enrico Spinas; Francesca Farnetani; Annunziata Dattola; Eleonora Di Matteo; Giovanni Pellacani; Luca Giannetti
Journal:  Dermatol Pract Concept       Date:  2021-09-01

5.  Taxifolin blocks monosodium urate crystal-induced gouty inflammation by regulating phagocytosis and autophagy.

Authors:  Mei-Hua Piao; Hui Wang; Yin-Jing Jiang; Yan-Ling Wu; Ji-Xing Nan; Li-Hua Lian
Journal:  Inflammopharmacology       Date:  2022-06-16       Impact factor: 5.093

6.  Colchicine Is a Weapon for Managing the Heart Disease Among Interstitial Lung Disease With Viral Infection: Have We Found the Holy Grail?

Authors:  Jun-Jun Yeh; Tuey-Wen Hung; Cheng-Li Lin; Tsung-Tse Chen; Pei-Xuan Liw; Ya-Lun Yu; Chia-Hung Kao
Journal:  Front Cardiovasc Med       Date:  2022-06-28

7.  Familial Mediterranean fever associated frosted branch angiitis, retinal vasculitis and vascular occlusion.

Authors:  Hana A Mansour; Pinar Ç Ozdal; Sibel Kadayifcilar; Ilknur Tugal-Tutkun; Hilal Eser-Ozturk; F Nilüfer Yalçındağ; Harry Petrushkin; Errol W Chan; Soukaina Belfaiza; Remzi Karadag; Sirel Gür Güngör; Maurizio Battaglia Parodi; Ahmad M Mansour
Journal:  Eye (Lond)       Date:  2021-11-01       Impact factor: 4.456

Review 8.  Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury.

Authors:  Stefano Toldo; Adolfo G Mauro; Zachary Cutter; Antonio Abbate
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-31       Impact factor: 4.733

Review 9.  Unconventional uses of common conventional drugs: A review.

Authors:  Anupam Das; Abheek Sil; Shouvik Ghosh; Saumya Panda
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jul-Aug       Impact factor: 2.545

10.  Colchicine effectively attenuates inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) in patients with non-ST-segment elevation myocardial infarction: a randomised, double-blind, placebo-controlled clinical trial.

Authors:  Arash Gholoobi; Vahid Reza Askari; Hossein Naghedinia; Mostafa Ahmadi; Vida Vakili; Vafa Baradaran Rahimi
Journal:  Inflammopharmacology       Date:  2021-08-21       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.